FIBROGEN INC·4

Sep 6, 8:55 PM ET

Eisner Mark 4

4 · FIBROGEN INC · Filed Sep 6, 2023

Insider Transaction Report

Form 4
Period: 2023-09-01
Eisner Mark
Incoming Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2023-09-01$1.06/sh1,085$1,150161,777 total
Footnotes (1)
  • [F1]Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24

    POA DOCUMENT